The FDA has proposed removing the boxed warning for menopausal hormone therapy, focusing on local estrogen use and reassessing risks and benefits.

Many long-COVID symptoms in people older than 65 years mimic signs of early aging, particularly cognitive, cardiac, and kidney issues.